Who owns NRX PHARMACEUTICALS INC?
- Ticker: NRXP
- CUSIP Number: 629444209
Tip: Access positions for across all investors
Analyze quarterly positions in Nrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nrx Pharmaceuticals stock
Who bought or sold NRX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 240k | $406k | 0% | Sep 2024 |
|
| Frigate Ventures | 143k | $241k | 100% | Sep 2024 |
|
| AdvisorShares Investments | 130k | $220k | 20% | Sep 2024 |
|
| Geode Capital Management | 77k | $131k | 18% | Sep 2024 |
|
| Citadel Advisors | 36k | $61k | 56% | Sep 2024 |
|
| Sabby Management | 35k | $59k | 100% | Sep 2024 |
|
| BlackRock | 29k | $49k | 100% | Sep 2024 |
|
| Susquehanna International | 21k | $35k | -66% | Sep 2024 |
|
| State Street Corporation | 17k | $28k | 0% | Sep 2024 |
|
| One Wealth Management Investment & Advisory Services | 15k | $33k | 0% | Dec 2024 |
|
| Townsquare Capital | 15k | $25k | 100% | Sep 2024 |
|
| Bank of America Corporation | 3.3k | $5.6k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 2.7k | $4.5k | 77% | Sep 2024 |
|
| Tower Research Capital | 2.5k | $4.3k | -24% | Sep 2024 |
|
| Goss Wealth Management | 83.00 | $139.996100 | -86% | Sep 2024 |
|
| Carolina Wealth Advisors | 50.00 | $110.000000 | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 50.00 | $83.825000 | 47% | Sep 2024 |
|
| Harbour Investments | 47.00 | $79.002300 | 0% | Sep 2024 |
|
| UBS Group | 38.00 | $63.999600 | -97% | Sep 2024 |
|
| Larson Financial Group | 22.00 | $36.999600 | 0% | Sep 2024 |
|
Who sold out of Nrx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2024 | 17k | $42k |
| Royal Bank of Canada | Jun 2024 | 4.0k | $0 |
| Qube Research & Technologies | Jun 2024 | 117.00 | $285.000300 |